Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma

Clinical trial NCT06058663 · RECRUITING

Trial details

NCT number: NCT06058663
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Intrahepatic Cholangiocarcinoma Oligometastatic Intrahepatic Cholangiocarcinoma Stage III Intrahepatic Cholangiocarcinoma AJCC v8 Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 Unresectable Intrahepatic Cholangiocarcinoma

Start date: 2024-06-06
Primary completion: 2026-11-30
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.